1. Home
  2. DTM vs EXAS Comparison

DTM vs EXAS Comparison

Compare DTM & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DTM
  • EXAS
  • Stock Information
  • Founded
  • DTM 2021
  • EXAS 1995
  • Country
  • DTM United States
  • EXAS United States
  • Employees
  • DTM N/A
  • EXAS N/A
  • Industry
  • DTM Oil & Gas Production
  • EXAS Medical Specialities
  • Sector
  • DTM Utilities
  • EXAS Health Care
  • Exchange
  • DTM Nasdaq
  • EXAS Nasdaq
  • Market Cap
  • DTM 10.8B
  • EXAS 10.7B
  • IPO Year
  • DTM N/A
  • EXAS N/A
  • Fundamental
  • Price
  • DTM $103.39
  • EXAS $51.91
  • Analyst Decision
  • DTM Buy
  • EXAS Strong Buy
  • Analyst Count
  • DTM 11
  • EXAS 20
  • Target Price
  • DTM $107.64
  • EXAS $70.26
  • AVG Volume (30 Days)
  • DTM 948.2K
  • EXAS 2.8M
  • Earning Date
  • DTM 07-29-2025
  • EXAS 07-30-2025
  • Dividend Yield
  • DTM 3.19%
  • EXAS N/A
  • EPS Growth
  • DTM N/A
  • EXAS N/A
  • EPS
  • DTM 3.68
  • EXAS N/A
  • Revenue
  • DTM $1,044,000,000.00
  • EXAS $2,828,128,000.00
  • Revenue This Year
  • DTM $24.87
  • EXAS $14.58
  • Revenue Next Year
  • DTM $7.67
  • EXAS $12.75
  • P/E Ratio
  • DTM $28.11
  • EXAS N/A
  • Revenue Growth
  • DTM 10.83
  • EXAS 11.57
  • 52 Week Low
  • DTM $69.82
  • EXAS $39.97
  • 52 Week High
  • DTM $114.50
  • EXAS $72.83
  • Technical
  • Relative Strength Index (RSI)
  • DTM 44.95
  • EXAS 44.34
  • Support Level
  • DTM $99.94
  • EXAS $52.00
  • Resistance Level
  • DTM $106.50
  • EXAS $55.90
  • Average True Range (ATR)
  • DTM 2.67
  • EXAS 2.31
  • MACD
  • DTM -0.69
  • EXAS -0.04
  • Stochastic Oscillator
  • DTM 30.89
  • EXAS 24.90

About DTM DT Midstream Inc.

DT Midstream Inc is an owner, operator, and developer of natural gas midstream interstate and intrastate pipelines; storage and gathering systems; and compression, treatment, and surface facilities. It provides multiple, integrated natural gas services to customers through interstate pipelines, intrastate pipelines, storage systems, lateral pipelines and related treatment plants and compression and surface facilities, and gathering systems and related treatment plants and compression and surface facilities. The segments of the group are Pipeline and Gathering. It generates revenue from pipeline, storage, and gathering systems, substantially all of which are located in the Midwestern U.S., Eastern Canada, Northeastern U.S., and Gulf Coast regions.

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

Share on Social Networks: